• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

埃及白塞病患者的白细胞介素-17、白细胞介素-10、白细胞介素-6 和干扰素-γ:与临床表现的相关性。

IL-17, IL-10, IL-6, and IFN-γ in Egyptian Behçet's disease: correlation with clinical manifestations.

机构信息

Molecular Biology Department, Genetic Engineering and Biotechnology Research Institute (GEBRI), University of Sadat City, Egypt.

National Research Centre (NRC), Medical Physiology Department, Egypt.

出版信息

Eur Cytokine Netw. 2019 Mar 1;30(1):15-22. doi: 10.1684/ecn.2019.0421.

DOI:10.1684/ecn.2019.0421
PMID:31122907
Abstract

There are a limited number of studies that report the polarization of the immune system toward the production of T helper 1 (Th1), Th2, or Th17-type cytokines in patients with Behçet's disease (BD). Here, we aimed to detect the presence of various cytokines in serum samples of Egyptian BD patients and to determine the correlation between their production levels and clinical manifestations. To that aim, serum levels of IFN-γ, IL-10, IL-6, and IL-17 measured by ELISA were determined in BD patients with active or inactive disease to evaluate their clinical relevance. The results of the present study show significantly elevated levels of IL-17 and IL-6, as well as a reduction in IL-10, and no change in IFN-γ, in sera of BD patients, as compared to the healthy control group. Moreover, IL-6 serum levels were increased in BD patients in active stages of disease and correlated with arthritic manifestations. On the other hand, IL-10 serum levels were significantly decreased in patients with gastrointestinal tract complications. Furthermore, a positive correlation was observed between IL-10 serum levels and ocular manifestations in BD patients, in contrast to those of IL-17, showing no correlation with the different clinical manifestations. Taken together, the magnitude of IL-6 serum levels could be a potential marker for arthritic manifestations and disease activity, whereas those of IFN-γ, IL-10, and IL-17 cannot be considered predictors for different clinical manifestations in patients with BD.

摘要

目前仅有少数研究报告了贝切特病(BD)患者的免疫系统向产生辅助性 T 细胞 1(Th1)、Th2 或 Th17 型细胞因子的极化。在这里,我们旨在检测埃及 BD 患者血清样本中各种细胞因子的存在,并确定其产生水平与临床表现之间的相关性。为此,通过 ELISA 测定 BD 患者活动期和非活动期血清中 IFN-γ、IL-10、IL-6 和 IL-17 的水平,以评估其临床相关性。本研究结果表明,与健康对照组相比,BD 患者血清中 IL-17 和 IL-6 水平显著升高,IL-10 水平降低,IFN-γ 水平无变化。此外,BD 患者活动期关节炎表现时血清中 IL-6 水平升高。另一方面,胃肠道并发症患者的血清 IL-10 水平显著降低。此外,BD 患者中观察到 IL-10 血清水平与眼部表现呈正相关,而与 IL-17 则无相关性。总之,IL-6 血清水平的高低可能是关节炎表现和疾病活动的潜在标志物,而 IFN-γ、IL-10 和 IL-17 不能作为 BD 患者不同临床表现的预测因子。

相似文献

1
IL-17, IL-10, IL-6, and IFN-γ in Egyptian Behçet's disease: correlation with clinical manifestations.埃及白塞病患者的白细胞介素-17、白细胞介素-10、白细胞介素-6 和干扰素-γ:与临床表现的相关性。
Eur Cytokine Netw. 2019 Mar 1;30(1):15-22. doi: 10.1684/ecn.2019.0421.
2
Cytokine profile in Behçet's disease patients. Relationship with disease activity.白塞病患者的细胞因子谱。与疾病活动的关系。
Scand J Rheumatol. 2002;31(4):205-10. doi: 10.1080/030097402320318387.
3
Elevated levels of interleukin-27 and effect on production of interferon-γ and interleukin-17 in patients with Behçet's disease.白塞病患者白细胞介素-27 水平升高及其对干扰素-γ和白细胞介素-17 产生的影响。
Scand J Rheumatol. 2013;42(1):48-51. doi: 10.3109/03009742.2012.704391. Epub 2012 Oct 26.
4
Up-regulation of Th17 and related cytokines in Behçet's disease corresponding to disease activity.白塞病患者 Th17 及其相关细胞因子的上调与疾病活动度相对应。
Clin Exp Rheumatol. 2013 May-Jun;31(3 Suppl 77):32-40. Epub 2013 Sep 9.
5
Excessive CD4+ T cells co-expressing interleukin-17 and interferon-γ in patients with Behçet's disease.白塞病患者中过度表达白细胞介素-17 和干扰素-γ 的 CD4+T 细胞。
Clin Exp Immunol. 2012 Apr;168(1):68-74. doi: 10.1111/j.1365-2249.2011.04543.x.
6
Serum Levels of IL-4, IL-10, IL-12, IL-13 and IFN-gamma in Behçet's disease.白塞病患者血清中白细胞介素-4、白细胞介素-10、白细胞介素-12、白细胞介素-13和干扰素-γ的水平
J Dermatol. 2003 Aug;30(8):602-7. doi: 10.1111/j.1346-8138.2003.tb00442.x.
7
Th17-Inducing Conditions Lead to in vitro Activation of Both Th17 and Th1 Responses in Behcet's Disease.诱导Th17的条件导致白塞病中Th17和Th1反应的体外激活。
Immunol Invest. 2017 Jul;46(5):518-525. doi: 10.1080/08820139.2017.1306865. Epub 2017 Apr 17.
8
Vitamin D modulates peripheral immunity in patients with Behçet's disease.维生素 D 可调节白塞病患者的外周免疫。
Clin Exp Rheumatol. 2010 Jul-Aug;28(4 Suppl 60):S50-7. Epub 2010 Sep 24.
9
IL-22-secreting Th22 and IFN-γ-secreting Th17 cells in Behçet's disease.白塞病中分泌白细胞介素-22的Th22细胞和分泌干扰素-γ的Th17细胞
Mod Rheumatol. 2014 Sep;24(5):802-7. doi: 10.3109/14397595.2013.879414. Epub 2014 Feb 5.
10
Imbalance of Th17 to Th1 cells in Behçet's disease.白塞病中 Th17 与 Th1 细胞失衡。
Clin Exp Rheumatol. 2010 Jul-Aug;28(4 Suppl 60):S16-9. Epub 2010 Sep 23.

引用本文的文献

1
Examining Sirtuin-1 Levels and Inflammation Markers in Behcet's Disease: A Pilot Study.白塞病中Sirtuin-1水平与炎症标志物的检测:一项初步研究
Arch Rheumatol. 2025 Jun 23;40(2):182-188. doi: 10.5152/ArchRheumatol.2025.11042.
2
Expression Levels of lncRNA NEAT1, miRNA-21, and IL-17 in a Group of Egyptian Patients with Behçet's Disease: Relation to Disease Manifestations and Activity.一组埃及白塞病患者中长链非编码RNA NEAT1、微小RNA-21和白细胞介素-17的表达水平:与疾病表现和活动的关系
Biologics. 2024 Nov 12;18:327-337. doi: 10.2147/BTT.S493191. eCollection 2024.
3
High Manganese Content of Lipid NanoMn (LNM) by Microfluidic Technology for Enhancing Anti-Tumor Immunity.
通过微流控技术制备的脂质纳米锰(LNM)的高锰含量用于增强抗肿瘤免疫力
Pharmaceutics. 2024 Apr 19;16(4):556. doi: 10.3390/pharmaceutics16040556.
4
Characteristics of pain and their relationship to disease activity in UK patients with Behçet's syndrome: a prospective cohort study.英国白塞病患者的疼痛特征及其与疾病活动的关系:一项前瞻性队列研究。
Br J Pain. 2023 Dec;17(6):560-568. doi: 10.1177/20494637231198200. Epub 2023 Aug 29.
5
Behçet's Disease Uveitis.白塞病性葡萄膜炎
J Clin Med. 2023 May 24;12(11):3648. doi: 10.3390/jcm12113648.
6
The proportion of C1q-high and ISG15-high monocytes in the skin of patients with Behçet disease.白塞病患者皮肤中C1q高表达和ISG15高表达单核细胞的比例。
Front Pharmacol. 2023 Mar 7;14:1110741. doi: 10.3389/fphar.2023.1110741. eCollection 2023.
7
Finding the Needle in the Haystack: Serological and Urinary Biomarkers in Behçet's Disease: A Systematic Review.从海量数据中寻找关键线索:白塞病的血清学和尿液生物标志物:系统评价。
Int J Mol Sci. 2023 Feb 3;24(3):3041. doi: 10.3390/ijms24033041.
8
New insights on multigenic autoinflammatory diseases.多基因自身炎症性疾病的新见解
Ther Adv Musculoskelet Dis. 2022 Sep 3;14:1759720X221117880. doi: 10.1177/1759720X221117880. eCollection 2022.
9
Clinical characteristics and risk factors of intestinal involvement in Behçet's syndrome patients: a cross-sectional study from a single center.Behçet 综合征患者肠道受累的临床特征及危险因素:一项单中心横断面研究。
Orphanet J Rare Dis. 2021 Mar 17;16(1):132. doi: 10.1186/s13023-021-01772-x.